Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.

Gallery

Contacts

411 University St, Seattle, USA

+1 -800-456-478-23

Events

Myeloid Therapeutics to Participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

CAMBRIDGE, Mass, April 15, 2024 – Myeloid Therapeutics, Inc. (“Myeloid”), a clinical stage biotechnology company advancing RNA immunotherapies to conquer cancer, today announced its participation at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit, taking place virtually April 29-30.

Daniel Getts, Ph.D., Chief Executive Officer of Myeloid, will participate in a fireside chat on Monday, April 29, 2024, at 11:30 am ET. Company management will also participate in one-on-one meetings with investors during the event.

About Myeloid Therapeutics

Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in Cambridge, MA. For additional information, please visit https://myeloidtx.com/ and follow us on LinkedIn and X/Twitter.

Investor Contact
Amy Conrad
Juniper Point
[email protected]